KCNJ11 activating mutations cause both transient and permanent neonatal diabetes mellitus in Cypriot patients

Area of Science:

• Genetics
• Endocrinology
• Molecular Biology

Background:

• Permanent neonatal diabetes mellitus (PNDM) diagnosed before six months of age is often caused by heterozygous mutations in the KCNJ11 gene, which encodes the Kir6.2 subunit of the pancreatic ATP-sensitive potassium (K(ATP)) channel.
• The K(ATP) channel is crucial for regulating pancreatic beta-cell membrane potential and subsequent insulin secretion.

Observation:

• This study investigated two Cypriot patients with diabetes onset before six months of age, both found to have KCNJ11 gene mutations.
• One patient had the R201H mutation, presenting with hyperglycemia and ketoacidosis, and responded well to sulfonylureas.
• The other patient had the R50Q mutation, experiencing transient diabetes with remission at nine months, with the same mutation found in their asymptomatic mother and diabetic grandmother.

Findings:

• The R201H mutation in KCNJ11 was associated with severe neonatal diabetes responsive to sulfonylureas.
• The R50Q mutation was linked to transient neonatal diabetes, with affected family members exhibiting varying phenotypes.
• The study suggests a potential correlation between mutation residue, ATP sensitivity, and diabetic phenotype severity in KCNJ11-related diabetes.

Implications:

• These findings highlight the critical role of KCNJ11 mutations in neonatal diabetes and underscore the importance of genetic diagnosis for tailored treatment strategies.
• The identification of different mutation types and their associated phenotypes aids in understanding the spectrum of KCNJ11-related diabetes.
• Further research into the remission-relapse mechanisms in transient neonatal diabetes is warranted to elucidate the underlying pathophysiology.